Sort by
Keyphrases
2,4-Diaminopyrimidine
72%
Active Compounds
24%
Adenocarcinoma Cells
36%
Anticancer Activity
36%
Anticryptosporidial
36%
Antifungal Activity
36%
Antimalarial Activity
72%
Biological Evaluation
36%
Calf Model
18%
Chagas Disease
36%
Cheminformatics
21%
Cryptosporidium
36%
Drug Development
36%
Drug Discovery
36%
Drug Metabolism
36%
Efficacy in Vivo
36%
Esophageal Adenocarcinoma
36%
Evaluation Structure
36%
Excellent Selectivity
21%
Guided Optimization
36%
Guided Synthesis
36%
Human Microsomes
21%
Humanized Models
36%
IC50
33%
Infectious Diseases
45%
Lipophilicity
36%
LysR Family
36%
Mammalian Cytotoxicity
30%
Metabolism
24%
Mouse Infection
30%
Mycobacterium Tuberculosis (M. tb)
48%
Niclosamide
36%
Niclosamide Derivatives
36%
Pentafluorophenyl
36%
Physicochemical Properties
54%
Pks13
36%
Plasmodium Falciparum
27%
Plasmodium Falciparum 3D7
24%
Protease Inhibitors
36%
Pyridazinone
36%
Quantitative Structure-activity Relationship
36%
Rat Microsomes
21%
Salicylanilide
36%
Structure-activity Relationship Studies
36%
Structure-based Design
36%
Sulfanyl
36%
Triethanolamine
24%
Trypanosoma Cruzi (T. cruzi)
48%
Urea
36%
Wild Mice
24%
Pharmacology, Toxicology and Pharmaceutical Science
2,4 Diaminopyrimidine Derivative
9%
Active Metabolite
12%
Antifungal Activity
36%
Antimalarial Activity
72%
Antimalarial Agent
36%
Buffer
9%
Carbanilamide
12%
Chagas Disease
36%
Chloroquine
9%
Cryo-Electron Microscopy
12%
Cryptosporidiosis
9%
Cryptosporidium
36%
Cytochrome P450
12%
Cytotoxicity
42%
Diseases
42%
Drug Development
36%
Drug Discovery
36%
Drug Metabolism
36%
Drug-Drug Interaction
12%
Efficacy Assessment
12%
Efficacy Study
12%
Esophageal Adenocarcinoma
21%
Ethanolamine
14%
Gastrointestinal Infection
9%
IC50
23%
Infection
100%
Intrinsic Clearance
9%
Leishmania
12%
Leishmania donovani
12%
Lipophilicity
36%
Lysine Transfer RNA Ligase
36%
Mouse Model
30%
Mycobacterium Tuberculosis
48%
Niclosamide
36%
Nitazoxanide
9%
Parasitosis
12%
Pharmaceutical Chemistry
18%
Pharmacokinetics
21%
Plasmodium falciparum
27%
Plasmodium Falciparum 3D7
24%
Proteasome
36%
Proteasome Inhibitor
36%
Pyrimidine
36%
Pyrimidine Derivative
12%
QSAR Study
36%
Salicylanilide Derivative
21%
Sulfanyl
36%
Trypanosoma Cruzi
48%
Visceral Leishmaniasis
12%
Wild Type Mouse
24%